JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ARTHUR, M. S.
Right arrow Articles by FLEMING, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ARTHUR, M. S.
Right arrow Articles by FLEMING, W. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 162, Issue 2, 263-269, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECTS OF TYRAMINE ON THE ISOLATED NICTITATING MEMBRANE OF THE CAT

MARK S. ARTHUR 1 and WILLIAM W. FLEMING 1

1 Department of Pharmacology, West Virginia University Medical Center, Morgantown, West Virginia

Dose-response curves to tyramine in the nictitating membrane in vitro have been studied under a variety of conditions. In control preparations, the cumulative method of obtaining the dose-response curve results in a higher maximum response than the noncumulative method. Pretreatment with reserpine or denervation shifts the curve to the right. Denervation also depresses the maximum. However, in denervated preparations the maximum response is the same regardless of whether it is determined by the cumulative or the noncumulative method. The response of the denervated nictitating membrane is markedly antagonized by phentolamine but not by atropine. It is concluded that tyramine, at higher doses, has a direct effect on the nictitating membrane which is unmasked by reducing the norepinephrine stores. This direct action seems to be mediated primarily by alpha adrenergic receptors.

Submitted on August 10, 1967
Accepted on March 22, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.